Correspondence 0001213900-23-065077 from Qomolangma Acquisition Corp. (QOMO, QOMOR, QOMOU, QOMOW) (CIK 0001894210)
Qomolangma Acquisition Corp. (QOMO, QOMOR, QOMOU, QOMOW) (CIK 0001894210)
Date: Aug. 9, 2023 · CIK: 0001894210 · Accession: 0001213900-23-065077
AI Filing Summary & Sentiment
File numbers found in text: 001-41518
Referenced dates: August 3, 2023
Show Raw Text
CORRESP
1
filename1.htm
Christopher S. Auguste
Partner
T 212.715.9265
cauguste@kramerlevin.com
1177 Avenue of the Americas
New York, NY 10036
T 212.715.9100
F 212.715.8000
August 9, 2023
VIA EDGAR CORRESPONDENCE
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Energy & Transportation
100 F Street, N.E.
Washington, D.C. 20549
Attention: Gus Rodriguez, Staff Accountant
Re: Qomolangma Acquisition Corp.
Form 10-K for the Fiscal Year ended December 31, 2022
Filed April 7, 2023
File No. 001-41518
Dear Mr. Rodriguez:
Reference is made to the letter dated August 3,
2023 (the “Comment Letter”) addressed to Mr. Jonathan P. Myers, setting forth the comments of the staff of the Securities
and Exchange Commission (the “Staff”) regarding the above-referenced Form 10-K filed by Qomolangma Acquisition Corp. (the
“Company”) with the Securities and Exchange Commission.
This letter sets forth the responses
of the Company to the Staff’s comments. For your convenience, the Staff’s comments contained in the Comment Letter have been
restated below in their entirety, with the response to each comment set forth immediately under that comment. The numbered paragraphs
in this letter correspond to the numbered paragraphs of the Comment Letter.
Form 10-K for the Fiscal Year ended December
31, 2022
Risk Factors, page 16
1. We note that you provided risk
factor disclosures in the Proxy Statement that you filed on June 13, 2023, to explain that you may be considered a “foreign person”
under the regulations administered by the Committee on Foreign Investment in the United States (CFIUS), because your Sponsor is controlled
by and has substantial ties with non-U.S. persons, and to discuss various risks associated with this designation.
We believe that you should provide similar
risk factor disclosures in your periodic reports, having a clear focus on the prospect of completing your initial business combination
and the concerns referenced in each of the following points.
● Discuss the risk to investors that you may not be able
to complete an initial business combination with a U.S. target company if the transaction becomes subject to review by a U.S. government
entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.
In response to the Staff’s comment,
the Company will include the following disclosure in its future periodic reports:
We may not be able to complete an initial
business combination with a U.S. target company if such initial business combination is subject to U.S. foreign investment regulations
and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.
The Company’s Sponsor is controlled
by and it has substantial ties with non-U.S. persons. As a result, the Company may be considered a “foreign person” under
the regulations administered by CFIUS. If our initial business combination with a U.S. business is subject to CFIUS review,
the scope of which was expanded by the Foreign Investment Risk Review Modernization Act of 2018 (“FIRRMA”), to include
certain non-passive, non-controlling investments in sensitive U.S. businesses and certain acquisitions of real estate even with
no underlying U.S. business, FIRRMA, and subsequent implementing regulations that are now in force, also subjects certain categories
of investments to mandatory filings. If our potential initial business combination with a U.S. business falls within CFIUS’s
jurisdiction, we may determine that we are required to make a mandatory filing or that we will submit a voluntary notice to CFIUS, or
to proceed with the initial business combination without notifying CFIUS and risk CFIUS intervention, before or after closing the initial
business combination. CFIUS may decide to block or delay our initial business combination, impose conditions to mitigate national security
concerns with respect to such initial business combination or order us to divest all or a portion of a U.S. business of the combined
company without first obtaining CFIUS clearance, which may limit the attractiveness of or prevent us from pursuing certain initial business
combination opportunities that we believe would otherwise be beneficial to us and our shareholders.
● Explain that as a result, the pool of potential targets
with which you could complete an initial business combination may be limited.
In response to the Staff’s comment,
the Company will include the following disclosure in its future periodic reports:
As a result (of the foregoing disclosure), the pool of potential
targets with which we could complete an initial business combination may be limited and we may be adversely affected in terms of competing
with other special purpose acquisition companies which do not have similar foreign ownership issues.
● Explain that the time necessary for government review
of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require
you to liquidate.
In response to the Staff’s comment,
the Company will include the following disclosure in its future periodic reports:
Moreover, the process of government
review, whether by the CFIUS or otherwise, could be lengthy and we have limited time to complete our initial business combination. If
we cannot complete our initial business combination within the timeframe required by the Company’s charter because the review process
drags on beyond such timeframe or because our initial business combination is ultimately prohibited by CFIUS or another U.S. government
entity, we may be required to liquidate.
● Discuss the consequences of liquidation to investors,
such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants
that would expire worthless.
In response to the Staff’s comment,
the Company will include the following disclosure in its future periodic reports:
If we liquidate, our public stockholders
may only receive an amount per share that will be determined by when we liquidate and whether the timeframe for us to complete a business
combination has been extended, and our warrants will expire worthless. This will also cause you to lose the investment opportunity in
a target company and the chance of realizing future gains on your investment through any price appreciation in the combined company.
If you have any questions or comments regarding
the responses of the Company to the Staff’s Comment Letter, please do not hesitate to contact me at (212) 715-9265.
Sincerely,
Christopher S. Auguste
CSA:cr
cc:
Jonathan Myers